CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angrand, P. O.
Right arrow Articles by Weiss, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angrand, P. O.
Right arrow Articles by Weiss, M. C.

Cell Growth & Differentiation, Vol 5, Issue 9 957-966, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids depends on the integrity of the cAMP pathway

PO Angrand, C Coffinier and MC Weiss
Unite de Genetique de la Differenciation, URA 1149 du Centre National de la Recherche Scientifique, Departement de Biologie Moleculaire, Institut Pasteur, Paris, France.

The phosphoenolpyruvate carboxykinase (PEPCK) gene is regulated at the transcriptional level by a variety of effectors in a tissue-specific fashion. In order to study the parameters involved in the tissue-specific hormonal regulation of the PEPCK gene, we have used a transient expression test in well-differentiated rat hepatoma cells as well as in dedifferentiated variants. In this test, the PEPCK promoter is induced by glucocorticoids in well-differentiated FGC4 cells, but not in H5 dedifferentiated variants, in spite of the presence in H5 cells of the glucocorticoid receptor. Study of the PEPCK promoter using electrophoretic mobility shift assays reveals binding sites for the liver-enriched transcription factors HNF1, vHNF1, HNF3, HNF4, and CAAT/enhancer binding protein members. Overexpression of the liver-enriched transcription factors absent in the dedifferentiated variants, such as HNF1 and HNF4, is not sufficient to restore glucocorticoid response of the PEPCK promoter in the variants. Moreover, systematic analysis of the PEPCK promoter reveals that the presence of a region covering a cAMP-responsive element (CRE1 at -80) and a CAAT box is necessary for full response of the PEPCK promoter to glucocorticoids in well-differentiated rat hepatoma cells. In a cotransfection test, overexpression of the regulatory subunit of protein kinase A (PKA), causing sequestering of PKA, abolishes the glucocorticoid response of the promoter in well-differentiated cells. On the other hand, in dedifferentiated variants, overexpression of the catalytic subunit of PKA restores the response to glucocorticoids. The action of PKA on the glucocorticoid response requires the presence of the CRE1 element and is promoter specific because it does not concern nonhepatic promoters such as the long terminal repeats of the mouse mammary tumor virus. These results suggest that the full response of the PEPCK promoter to glucocorticoids requires activation of another signal transduction pathway, the cAMP-mediated pathway.


This article has been cited by other articles:


Home page
BloodHome page
E. E. Romero, U. Marvi, Z. E. Niman, and D. A. Roth
The vitamin K-dependent {gamma}-glutamyl carboxylase gene contains a TATA-less promoter with a novel upstream regulatory element
Blood, August 15, 2003; 102(4): 1333 - 1339.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Gregori, A. Porteu, C. Mitchell, A. Kahn, and A.-L. Pichard
In Vivo Functional Characterization of the Aldolase B Gene Enhancer
J. Biol. Chem., August 9, 2002; 277(32): 28618 - 28623.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Waltner-Law, M. C. Daniels, C. Sutherland, and D. K. Granner
NF-{kappa}B Inhibits Glucocorticoid and cAMP-mediated Expression of the Phosphoenolpyruvate Carboxykinase Gene
J. Biol. Chem., October 13, 2000; 275(41): 31847 - 31856.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Yamada, D. T. Duong, D. K. Scott, J.-C. Wang, and D. K. Granner
CCAAT/Enhancer-binding Protein {beta} Is an Accessory Factor for the Glucocorticoid Response from the cAMP Response Element in the Rat Phosphoenolpyruvate Carboxykinase Gene Promoter
J. Biol. Chem., February 26, 1999; 274(9): 5880 - 5887.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. R. Magee, Y. Cai, M. E. El-Houseini, J. Locker, and Y.-J. Y. Wan
Retinoic Acid Mediates Down-regulation of the {alpha}-Fetoprotein Gene through Decreased Expression of Hepatocyte Nuclear Factors
J. Biol. Chem., November 6, 1998; 273(45): 30024 - 30032.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Waltner-Law, M. C. Daniels, C. Sutherland, and D. K. Granner
NF-{kappa}B Inhibits Glucocorticoid and cAMP-mediated Expression of the Phosphoenolpyruvate Carboxykinase Gene
J. Biol. Chem., October 13, 2000; 275(41): 31847 - 31856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.